Evaluation of Offset of Conjunctival Hyperemia Induced by a Rho-Kinase Inhibitor; 0.4% Ripasudil Ophthalmic Solution Clinical Trial
Scientific Reports - United Kingdom
doi 10.1038/s41598-019-40255-9
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 6, 2019
Authors
Publisher
Springer Science and Business Media LLC